Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P. Barker A, et al. Among authors: weets i. Diabetes Obes Metab. 2014 Mar;16(3):262-7. doi: 10.1111/dom.12216. Epub 2013 Oct 29. Diabetes Obes Metab. 2014. PMID: 24118704
BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.
Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P. Lauria A, et al. Among authors: weets i. Eur J Endocrinol. 2015 Feb;172(2):107-13. doi: 10.1530/EJE-14-0522. Epub 2014 Nov 6. Eur J Endocrinol. 2015. PMID: 25378371
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Gorus FK; Belgian Diabetes Registry. Decochez K, et al. Among authors: weets i. Diabetes Care. 2000 Aug;23(8):1072-8. doi: 10.2337/diacare.23.8.1072. Diabetes Care. 2000. PMID: 10937500
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients.
Vandemeulebroucke E, Gorus FK, Decochez K, Weets I, Keymeulen B, De Block C, Tits J, Pipeleers DG, Mathieu C; Belgian Diabetes Registry. Vandemeulebroucke E, et al. Among authors: weets i. Diabetes Metab. 2009 Sep;35(4):319-27. doi: 10.1016/j.diabet.2009.02.005. Epub 2009 Jul 31. Diabetes Metab. 2009. PMID: 19647467 Clinical Trial.
Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I, Weets I, Asanghanwa M, Ruige J, Van Gaal L, Mathieu C, Keymeulen B, Lampasona V, Wenzlau JM, Hutton JC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry. Vermeulen I, et al. Among authors: weets i. Diabetes Care. 2011 Aug;34(8):1760-5. doi: 10.2337/dc10-2268. Epub 2011 Jun 29. Diabetes Care. 2011. PMID: 21715527 Free PMC article.
Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetes.
Demeester S, Keymeulen B, Kaufman L, Van Dalem A, Balti EV, Van de Velde U, Goubert P, Verhaeghen K, Davidson HW, Wenzlau JM, Weets I, Pipeleers DG, Gorus FK. Demeester S, et al. Among authors: weets i. Diabetes Care. 2015 Apr;38(4):644-51. doi: 10.2337/dc14-1575. Epub 2015 Jan 12. Diabetes Care. 2015. PMID: 25583753 Free PMC article. Clinical Trial.
91 results